[1] Liu T, Zhou HJ, Min W. ASK family in cardiovascular biology and medicine[J]. Adv Biol Regul, 2017, 66: 54-62. [2] Amos LA, Ma FY, Tesch GH, et al. ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis[J]. J Cell Mol Med, 2018, 22: 4522-4533. [3] Lin JH, Zhang JJ, Lin SL, et al. Design of a phase 2 clinical trial of an ASK1 inhibitor, GS-4997, in patients with diabetic kidney disease[J]. Nephron, 2015, 129: 29-33. [4] Takeda K, Shimozono R, Noguchi T, et al. Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1[J]. J Biol Chem, 2007, 282: 7522-7531. [5] Watanabe K, Umeda T, Niwa K, et al. A PP6-ASK3 module coordinates the bidirectional cell volume regulation under osmotic stress[J]. Cell Rep, 2018, 22: 2809-2817. [6] Imamura K, Yoshitane H, Hattori K, et al. ASK family kinases mediate cellular stress and redox signaling to circadian clock[J]. Proc Natl Acad Sci U S A, 2018, 115: 3646-3651. [7] Naguro I, Umeda T, Kobayashi Y, et al. ASK3 responds to osmotic stress and regulates blood pressure by suppressing WNK1-SPAK/OSR1 signaling in the kidney[J]. Nat Commun, 2012, 3: 1285.doi:10.1038/nComms2283. [8] Tarifeño-Saldivia E, Lavergne A, Bernard A, et al. Transcriptome analysis of pancreatic cells across distant species highlights novel important regulator genes[J]. BMC Biol, 2017, 15: 21.doi:10.1186/s12915-017-0362-x. [9] Moreno-Mateos MA, Vejnar CE, Beaudoin JD, et al. CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo[J]. Nat Methods, 2015, 12: 982-988. [10] Chang N, Sun C, Gao L, et al. Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos[J]. Cell Res, 2013, 23: 465-472.doi:10.1093/nar/gku036. [11] Brinkman EK, Chen T, Amendola M, et al. Easy quantitative assessment of genome editing by sequence trace decomposition[J]. Nucleic Acids Res, 2014, 42: e168.doi:10.1093/nar/gku936. [12] Hanke N, Staggs L, Schroder P, et al. “Zebrafishing” for novel genes relevant to the glomerular filtration barrier[J]. Biomed Res Int, 2013, 2013: 658270.doi:10/1155/2013/658270. [13] Cuarental L, Sucunza-Sáenz D, Valiño-Rivas L, et al. MAP3K kinases and kidney injury[J]. Nefrologia (Engl Ed), 2019, 39: 568-580. [14] Mudumana SP, Hentschel D, Liu Y, et al. odd skipped related1 reveals a novel role for endoderm in regulating kidney versus vascular cell fate[J]. Development, 2008, 135: 3355-3367. [15] Zhang Z, Iglesias D, Eliopoulos N, et al. A variant OSR1 allele which disturbs OSR1 mRNA expression in renal progenitor cells is associated with reduction of newborn kidney size and function[J]. Hum Mol Genet, 2011, 20: 4167-4174. |